GPFA
CLSD

Game Plan Financial Advisors’s Clearside Biomedical CLSD Stock Holding History

Game Plan Financial Advisors’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-733
Closed -$32K – 93
2019
Q4 		$32K Buy
+733
New +$15.4K 0.03% 92

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Game Plan Financial Advisors's CLSD Position: Q1 2020 in Review

Game Plan Financial Advisors sold out of Clearside Biomedical (CLSD) in Q1 2020, closing a stake of 733 shares — an estimated $32K sold.

Game Plan Financial Advisors first reported a position in CLSD in Q4 2019 and held it in 1 quarter. The position peaked at $32K in Q4 2019. 43 funds tracked by Wall St. Rank hold CLSD as of Q1 2020.

  • Game Plan Financial Advisors reported no remaining Clearside Biomedical position as of Q1 2020 after selling out during the quarter.
  • Game Plan Financial Advisors sold 733 Clearside Biomedical shares in Q1 2020, an estimated $32K.
  • Game Plan Financial Advisors first reported a position in Clearside Biomedical in Q4 2019 and held it in 1 quarter.
  • Game Plan Financial Advisors's Clearside Biomedical position peaked at $32K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2020.

Based on Game Plan Financial Advisors's 13F filing for Q1 2020, filed 7 May 2020.